These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16054562)

  • 1. Keynote comment: nitrosatable drugs, cancer, and guidelines for genotoxicity.
    Brambilla G; Martelli A
    Lancet Oncol; 2005 Aug; 6(8):538-9. PubMed ID: 16054562
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of drug metabolites.
    Izumi T
    Drug Metab Pharmacokinet; 2011; 26(2):121-2. PubMed ID: 21532211
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug metabolites in safety testing.
    Hastings KL; El-Hage J; Jacobs A; Leighton J; Morse D; Osterberg RE
    Toxicol Appl Pharmacol; 2003 Jul; 190(1):91-2;author reply 93-4. PubMed ID: 12831788
    [No Abstract]   [Full Text] [Related]  

  • 4. Genotoxicity and carcinogenicity studies of bronchodilators and antiasthma drugs.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Basic Clin Pharmacol Toxicol; 2013 May; 112(5):302-13. PubMed ID: 23374861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How to use drugs in chronic renal insufficiency (antibiotics excepted)].
    Kleinknecht D
    Sem Hop Ther; 1976 Apr; 52(4):254-9. PubMed ID: 948770
    [No Abstract]   [Full Text] [Related]  

  • 6. Principles of drug therapy for the elderly patient.
    Bressler R; Bahl JJ
    Mayo Clin Proc; 2003 Dec; 78(12):1564-77. PubMed ID: 14661688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereochemical effects in the metabolic activation of nitrosopiperidines: correlations with genotoxicity.
    González-Mancebo S; Gaspar J; Calle E; Pereira S; Mariano A; Rueff J; Casado J
    Mutat Res; 2004 Mar; 558(1-2):45-51. PubMed ID: 15036118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report on the international workshop on the use of human in vitro liver preparations to study drug metabolism in drug development. Held at Utrecht, The Netherlands, 6-8 September 1994.
    Skett P; Tyson C; Guillouzo A; Maier P
    Biochem Pharmacol; 1995 Jul; 50(2):280-5. PubMed ID: 7632175
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse drug reactions in the elderly.
    Paton DM
    S Afr Med J; 1984 Jul; 66(3):84. PubMed ID: 6740437
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation of side-effects of drugs.
    Jacobs HD
    S Afr Med J; 1973 Aug; 47(30):1365-9. PubMed ID: 4721497
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenetics of drugs withdrawn from the market.
    Zhang W; Roederer MW; Chen WQ; Fan L; Zhou HH
    Pharmacogenomics; 2012 Jan; 13(2):223-31. PubMed ID: 22256871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs and genes.
    Lancet; 1973 Aug; 2(7823):247-8. PubMed ID: 4124432
    [No Abstract]   [Full Text] [Related]  

  • 13. [What is ICH? - Current status of non-clinical safety guidelines].
    Sagami F
    Nihon Yakurigaku Zasshi; 2007 Dec; 130(6):499-504. PubMed ID: 18079602
    [No Abstract]   [Full Text] [Related]  

  • 14. International Conference on Harmonisation; guidance on S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals intended for Human Use; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Jun; 77(110):33748-9. PubMed ID: 22675782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arylamine N-acetyltransferases and drug response.
    Meisel P
    Pharmacogenomics; 2002 May; 3(3):349-66. PubMed ID: 12052143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrosation of drugs under in-vivo conditions.
    Walters CL; Gillatt PN; Palmer RC; Smith PL; Reed PI
    IARC Sci Publ; 1987; (84):351-4. PubMed ID: 3679400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategic proposals for avoiding toxic interactions with drugs for clinical use during development and after marketing of a new drug: pharmacokinetic consideration.
    Sugiyama Y; Iwatsubo T; Ueda K; Ito K
    J Toxicol Sci; 1996 Dec; 21(5):309-16. PubMed ID: 9035043
    [No Abstract]   [Full Text] [Related]  

  • 18. Application of metabolic data to the evaluation of drugs.
    Azarnoff DL
    JAMA; 1970 Mar; 211(10):1691. PubMed ID: 5467089
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacokinetic consequences of aging].
    Scarpignato C; Cavaggioni AL
    Farmaco Prat; 1981 Mar; 36(3):111-28. PubMed ID: 7011841
    [No Abstract]   [Full Text] [Related]  

  • 20. [Technical studies & exactness on tissular & cellular localization of drugs & poisons].
    MASCHERPA P
    J Med Bord; 1957 May; 134(5):671-4. PubMed ID: 13449466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.